Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
3.630
-0.030 (-0.82%)
At close: Apr 25, 2025, 4:00 PM
3.700
+0.070 (1.93%)
After-hours: Apr 25, 2025, 7:54 PM EDT

Corvus Pharmaceuticals Statistics

Total Valuation

CRVS has a market cap or net worth of $247.33 million. The enterprise value is $196.49 million.

Market Cap 247.33M
Enterprise Value 196.49M

Important Dates

The next estimated earnings date is Monday, May 5, 2025, after market close.

Earnings Date May 5, 2025
Ex-Dividend Date n/a

Share Statistics

CRVS has 68.14 million shares outstanding. The number of shares has increased by 26.99% in one year.

Current Share Class 68.14M
Shares Outstanding 68.14M
Shares Change (YoY) +26.99%
Shares Change (QoQ) +2.47%
Owned by Insiders (%) 0.89%
Owned by Institutions (%) 36.28%
Float 52.15M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 7.57
P/TBV Ratio 7.59
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.03.

Current Ratio 1.54
Quick Ratio 1.47
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -174.85% and return on invested capital (ROIC) is -46.69%.

Return on Equity (ROE) -174.85%
Return on Assets (ROA) -30.08%
Return on Invested Capital (ROIC) -46.69%
Return on Capital Employed (ROCE) -82.22%
Revenue Per Employee n/a
Profits Per Employee -$2.01M
Employee Count 31
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +140.40% in the last 52 weeks. The beta is 0.70, so CRVS's price volatility has been lower than the market average.

Beta (5Y) 0.70
52-Week Price Change +140.40%
50-Day Moving Average 3.84
200-Day Moving Average 5.18
Relative Strength Index (RSI) 55.04
Average Volume (20 Days) 911,642

Short Selling Information

The latest short interest is 5.34 million, so 7.84% of the outstanding shares have been sold short.

Short Interest 5.34M
Short Previous Month 4.92M
Short % of Shares Out 7.84%
Short % of Float 10.24%
Short Ratio (days to cover) 6.48

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -27.55M
Pretax Income n/a
Net Income -62.29M
EBITDA -27.46M
EBIT -27.55M
Earnings Per Share (EPS) -$1.02
Full Income Statement

Balance Sheet

The company has $51.96 million in cash and $1.12 million in debt, giving a net cash position of $50.84 million or $0.75 per share.

Cash & Cash Equivalents 51.96M
Total Debt 1.12M
Net Cash 50.84M
Net Cash Per Share $0.75
Equity (Book Value) 32.57M
Book Value Per Share 0.48
Working Capital 19.01M
Full Balance Sheet

Cash Flow

Operating Cash Flow -25.42M
Capital Expenditures n/a
Free Cash Flow -25.42M
FCF Per Share -$0.37
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CRVS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -26.99%
Shareholder Yield n/a
Earnings Yield -25.19%
FCF Yield -10.28%

Analyst Forecast

The average price target for CRVS is $15.67, which is 331.68% higher than the current price. The consensus rating is "Strong Buy".

Price Target $15.67
Price Target Difference 331.68%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1